Regeneron posts Q4 beat as Sanofi collaboration offsets Eylea headwinds
Source: SeekingAlpha
2026-01-30 07:07:49 ET
More on Regeneron Pharmaceuticals, Sanofi, etc.
- Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript
- Sanofi 2025 Q4 - Results - Earnings Call Presentation
- Regeneron: Q4 Earnings Preview - Why I'm Expecting A Beat And Strong 2026
- Regeneron Pharmaceuticals beats top-line and bottom-line estimates; initiates FY26 outlook
- Regeneron Pharmaceuticals Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Regeneron posts Q4 beat as Sanofi collaboration offsets Eylea headwinds
Banco Santander S.A. Sponsored ADR
NASDAQ: SAN
SAN Trading
-3.62% G/L:
$10.925 Last:
5,039,679 Volume:
$11.02 Open:
SAN Latest News
February 03, 2026 01:38:00 pm
Webster Financial Corporation Enters Into Merger Agreement With Banco Santander, S.A. for $12.3 Billion
SAN Stock Data
$212,542,521,684
14,572,031,202
2.7%
312
N/A
Banking
Finance
ES
Boadilla del Monte
